TEHRAN - Iranian researchers have produced a nano-drug which has proven effective in battling treatment-resistant cancers.

The Cancer Research Center of Tehran University of Medical Sciences produced the polymer-based nano-carrier for the targeted release of the anti-cancer drug curcumin, ISNA reported on Sunday.

“This nano-carrier was made without the use of poisonous catalysts and has proven successful in clinical trials on a number cancer patients,” said Dr. Ali Mohammad Alizadeh from the Iran Nanotechnology Initiative Council.

Research has proven that curcumin, which is found in turmeric, has anti-cancer and cancer preventing properties apart from its anti-oxidant and anti-inflammatory properties, he added.

Even if prescribed in high dosages, the drug is proven not poisonous during first-stage clinical trials and is currently near the end of stage two clinical trials on drug-resistant breast and digestive tract cancers.
     
SP/P